FAKTOR OPTIONSSCHEIN - AMGEN | Market Closed - Deutsche Boerse AG 13:34:10 2024-05-13 EDT | ||
| 3.01 EUR | +5.24% |
|
| Current month | -37.03% | ||
| 1 month | -42.78% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
AMGEN INC.
Latest news about AMGEN INC.
More news
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-05-13 | 3.01 | +5.24% | 0 |
| 24-05-10 | 2.86 | +0.70% | 0 |
| 24-05-09 | 2.84 | -9.27% | 0 |
| 24-05-08 | 3.13 | -4.57% | 0 |
| 24-05-07 | 3.28 | +0.31% | 0 |
Delayed Quote Deutsche Boerse AG
Last update May 13, 2024 at 01:34 pm
More quotesStatic data
| Product type | Exotic Products |
|---|---|
| Buy / Sell | CALL |
| Underlying | AMGEN INC. |
| Issuer | UBS |
| WKN | UL740Z |
| ISIN | DE000UL740Z0 |
| Date issued | 2023-10-16 |
| Strike | 417.1 $ |
| Maturity | Unlimited |
| Parity | 33.34 : 1 |
| Emission price | 5.09 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 7.27 € |
|---|---|
| Lowest since issue | 2.49 € |
| Spread | 0.1 € |
| Spread % | 3.25% |
Company Profile
Amgen Inc. is one of the world's leading biotechnology groups. Net sales break down by source of revenue as follows:
- drug sales (94.2%): drugs for treating cancer, metabolic disorders, bone diseases, renal failure, hemophilia, etc.;
- other (5.8%): primarily royalties.
The United States account for 70.3% of net sales.
Sector
-
Consensus: Amgen Inc.
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
30
Last Close Price
308.4
USD
Average target price
314.6
USD
Spread / Average Target
+2.01%
- Stock Market
- Certificates
- Certificat